Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long COVID.

The inception of Open Medicine Foundation (OMF) traces back to the personal journey of its founder, Linda Tannenbaum. As OMF’s President and CEO, Linda’s motivation was deeply personal; her daughter, at the age of 16, was struck by ME/CFS, a diagnosis that came without the prospect of diagnostic tests or viable treatments. Confronted with the painful reality of her daughter’s diminished quality of life, Linda was propelled into action.

Her pursuit for answers revealed a stark void in collaborative and transparent research, as well as funding for ME/CFS and related chronic, complex diseases. Determined to bridge this gap, Linda established OMF in 2012, with a vision to catalyze large-scale research efforts aimed at creating diagnostic tools, effective treatments, and ultimately, prevention methodologies for these conditions.

Linda’s professional background as a clinical laboratory scientist, holding a bacteriology degree from UCLA, and her experience managing a clinical laboratory for over 20 years, have all converged to fuel her current mission. With unwavering dedication, Linda Tannenbaum now channels her expertise and passion into spearheading the quest to find a cure for chronic complex diseases, enhance patient care, and restore the lives of millions affected by these conditions.